Cell MedX Corp (CMXC)

Name: Cell MedX Corp Financial Statements
Creator: Quarter Results

Healthcare | Medical Devices

Latest reporting period: 2025-11-30

Latest Quarter

2025-11-30

Revenue

$0.0

Net Income

-$310K

Operating Margin

N/A

Free Cash Flow

-$142K

Debt / Assets

5,972.6%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Cell MedX Corp (CMXC).
Income Statement (Quarterly)	2025-11-30	2025-08-31	2025-02-28	2024-11-30
Revenue	0	0	0	0
Cost of Revenue	0	0	0	0
Gross Profit	0	0	0	0
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	163,598	139,484	32,847	57,424
Operating Expenses	271,498	252,354	131,086	79,924
Operating Income	-271,498	0	0	0
Interest Expense	16,702	0	0	8,810
Income Before Tax	-309,748	-265,602	-140,537	-139,508
Income Tax Expense	0	0	0	0
Net Income	-309,748	-265,602	-140,537	-139,508
Per Share
EPS	-0.01	-0.01	-0.01	-0.01
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Cell MedX Corp (CMXC).
Income Statement (Annual)	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31
Revenue	0	0	2,762	6,065	6,762
Cost of Revenue	0	0	2,279	2,032	3,240
Gross Profit	0	0	483	4,033	3,522
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	213,452	290,891	358,921	523,872	454,094
Operating Expenses	522,106	313,430	448,141	675,726	686,109
Operating Income	0	-313,430	-445,379	-671,693	-682,587
Interest Expense	0	61,651	47,384	25,686	-32,020
Income Before Tax	-566,293	-142,486	-495,042	-697,379	-910,836
Income Tax Expense	0	0	-170,174	25,686	0
Net Income	-566,293	-142,486	-495,042	-723,065	-910,836
Per Share
EPS	-0.03	0.00	-0.01	-0.01	-0.02
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Cell MedX Corp (CMXC).
Balance Sheet (Quarterly)	2025-05-31	2024-05-31	2023-05-31	2022-05-31
Assets
Cash and Cash Equivalents	14,581	43,415	98,295	24,380
Short Term Investments	0	0	0	0
Net Receivables	0	1,807	3,225	8,775
Inventory	0	0	0	-8,775
Total Current Assets	14,581	46,122	103,270	41,344
Property Plant Equipment	0	0	0	0
Goodwill and Intangibles	0	0	0	0
Total Assets	21,222	46,122	103,270	41,344
Liabilities
Account Payables	322,144	288,891	408,264	442,439
Short Term Debt	0	313,490	1,001,024	616,781
Total Current Liabilities	322,144	872,577	2,488,750	2,050,375
Long Term Debt	0	0	0	0
Total Liabilities	1,267,508	872,577	2,488,750	2,050,375
Shareholders Equity
Retained Earnings	-10,861,556	-10,295,263	-10,152,777	-9,657,735
Total Shareholders Equity	-1,246,286	-826,455	-2,385,480	-2,009,031

Balance sheet annual history for Cell MedX Corp (CMXC).
Balance Sheet (Annual)	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31
Assets
Cash and Cash Equivalents	14,581	43,415	98,295	24,380	20,753
Short Term Investments	0	0	0	0	0
Net Receivables	0	1,807	3,225	8,775	12,423
Inventory	0	0	0	-8,775	0
Total Current Assets	14,581	46,122	103,270	41,344	51,047
Property Plant Equipment	0	0	0	0	1,195
Goodwill and Intangibles	0	0	0	0	0
Total Assets	21,222	46,122	103,270	41,344	52,242
Liabilities
Account Payables	322,144	288,891	408,264	442,439	431,593
Short Term Debt	0	313,490	1,001,024	616,781	343,668
Total Current Liabilities	322,144	872,577	2,488,750	2,050,375	1,628,300
Long Term Debt	0	0	0	0	0
Total Liabilities	1,267,508	872,577	2,488,750	2,050,375	1,628,300
Shareholders Equity
Retained Earnings	-10,861,556	-10,295,263	-10,152,777	-9,657,735	-8,960,356
Total Shareholders Equity	-1,246,286	-826,455	-2,385,480	-2,009,031	-1,576,058

Cash flow quarterly history for Cell MedX Corp (CMXC).
Cash Flow Statement (Quarterly)	2025-05-31	2024-05-31	2023-05-31	2022-05-31
Operating Activities
Net Income	-566,293	-142,486	-495,042	-697,379
Depreciation & Amortization	0	0	0	1,145
Stock Based Compensation	0	0	0	0
Change in Working Capital	0	116,074	104,308	137,976
Operating Cash Flow	-141,600	-145,898	-272,209	-450,591
Investing Activities
Capital Expenditure	0	0	0	0
Investments	0	0	0	0
Investing Cash Flow	0	0	0	0
Financing Activities
Debt Repayment	0	16,033	-346,364	-293,971
Common Stock Issued/Repurchased	0	75,000	0	160,000
Dividends Paid	0	0	0	0
Financing Cash Flow	112,858	91,033	346,364	453,971
Summary
Free Cash Flow	-141,600	-145,898	-272,209	-450,591
Net Change in Cash	-28,834	-54,880	73,915	3,627

Cash flow annual history for Cell MedX Corp (CMXC).
Cash Flow Statement (Annual)	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31
Operating Activities
Net Income	-566,293	-142,486	-495,042	-697,379	-910,836
Depreciation & Amortization	0	0	0	1,145	2,434
Stock Based Compensation	0	0	0	0	0
Change in Working Capital	0	116,074	104,308	137,976	220,393
Operating Cash Flow	-141,600	-145,898	-272,209	-450,591	-560,432
Investing Activities
Capital Expenditure	0	0	0	0	-1,574
Investments	0	0	0	0	-1,574
Investing Cash Flow	0	0	0	0	-1,574
Financing Activities
Debt Repayment	0	16,033	-346,364	-293,971	0
Common Stock Issued/Repurchased	0	75,000	0	160,000	0
Dividends Paid	0	0	0	0	0
Financing Cash Flow	112,858	91,033	346,364	453,971	535,096
Summary
Free Cash Flow	-141,600	-145,898	-272,209	-450,591	-562,006
Net Change in Cash	-28,834	-54,880	73,915	3,627	-24,337